These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. ["Therapy-resistant polymyositis" - is the diagnosis correct?]. Ceccon G, Lehmann HC, Neuen-Jacob E, Meng G, Fink GR, Wunderlich G. Z Rheumatol; 2017 Sep; 76(7):640-643. PubMed ID: 28523511 [Abstract] [Full Text] [Related]
3. Phenotypic study in 40 patients with dysferlin gene mutations: high frequency of atypical phenotypes. Nguyen K, Bassez G, Krahn M, Bernard R, Laforêt P, Labelle V, Urtizberea JA, Figarella-Branger D, Romero N, Attarian S, Leturcq F, Pouget J, Lévy N, Eymard B. Arch Neurol; 2007 Aug; 64(8):1176-82. PubMed ID: 17698709 [Abstract] [Full Text] [Related]
4. New aspects on patients affected by dysferlin deficient muscular dystrophy. Klinge L, Aboumousa A, Eagle M, Hudson J, Sarkozy A, Vita G, Charlton R, Roberts M, Straub V, Barresi R, Lochmüller H, Bushby K. J Neurol Neurosurg Psychiatry; 2010 Sep; 81(9):946-53. PubMed ID: 19528035 [Abstract] [Full Text] [Related]
13. [Dysferlin expression in limb-girdle muscular dystrophy and Miyoshi myopathy: analysis of 45 cases]. Ren SC, Yan CZ, Li MX, Liu SP, Wu JL, Zhao YY, Li W, Li DN. Zhonghua Yi Xue Za Zhi; 2007 Jun 05; 87(21):1486-90. PubMed ID: 17785089 [Abstract] [Full Text] [Related]
14. Abnormal expression of dysferlin in skeletal muscle and monocytes supports primary dysferlinopathy in patients with one mutated allele. Meznaric M, Gonzalez-Quereda L, Gallardo E, de Luna N, Gallano P, Fanin M, Angelini C, Peterlin B, Zidar J. Eur J Neurol; 2011 Jul 05; 18(7):1021-3. PubMed ID: 21658164 [Abstract] [Full Text] [Related]
15. Dysferlin quantification in monocytes for rapid screening for dysferlinopathies. Sánchez-Chapul L, Ángel-Muñoz MD, Ruano-Calderón L, Luna-Angulo A, Coral-Vázquez R, Hernández-Hernández Ó, Magaña JJ, León-Hernández SR, Escobar-Cedillo RE, Vargas S. Muscle Nerve; 2016 Dec 05; 54(6):1064-1071. PubMed ID: 27104310 [Abstract] [Full Text] [Related]
17. Dysferlin-deficient muscular dystrophy features amyloidosis. Spuler S, Carl M, Zabojszcza J, Straub V, Bushby K, Moore SA, Bähring S, Wenzel K, Vinkemeier U, Rocken C. Ann Neurol; 2008 Mar 05; 63(3):323-8. PubMed ID: 18306167 [Abstract] [Full Text] [Related]
18. Late onset in dysferlinopathy widens the clinical spectrum. Klinge L, Dean AF, Kress W, Dixon P, Charlton R, Müller JS, Anderson LV, Straub V, Barresi R, Lochmüller H, Bushby K. Neuromuscul Disord; 2008 Apr 05; 18(4):288-90. PubMed ID: 18396043 [Abstract] [Full Text] [Related]
19. Limb-girdle muscular dystrophy type 2B misdiagnosed as polymyositis at the early stage: Case report and literature review. Xu C, Chen J, Zhang Y, Li J. Medicine (Baltimore); 2018 May 05; 97(21):e10539. PubMed ID: 29794729 [Abstract] [Full Text] [Related]
20. Novel diagnostic features of dysferlinopathies. Rosales XQ, Gastier-Foster JM, Lewis S, Vinod M, Thrush DL, Astbury C, Pyatt R, Reshmi S, Sahenk Z, Mendell JR. Muscle Nerve; 2010 Jul 05; 42(1):14-21. PubMed ID: 20544924 [Abstract] [Full Text] [Related] Page: [Next] [New Search]